Bliss GVS Pharma Ltd.
BSE: 506197 | Sector: Health care |
NSE: BLISSGVS | ISIN Code: INE416D01022 |
BSE 00:00 | 20 May | 72.20 |
0.75 (1.05%) |
OPEN
73.00 |
HIGH
74.10 |
LOW
71.40 |
NSE 00:00 | 20 May | 72.15 |
0.80 (1.12%) |
OPEN
72.00 |
HIGH
74.00 |
LOW
71.55 |
OPEN | 73.00 |
PREVIOUS CLOSE | 71.45 |
VOLUME | 18926 |
52-Week high | 128.40 |
52-Week low | 66.25 |
P/E | 8.26 |
Mkt Cap.(Rs cr) | 749 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bliss GVS Pharma Ltd. (BLISSGVS) - Financial Overview
Particulars (![]() |
2021 | 2020 | 2019 |
Net Sales | 465.51 | 441.95 | 426.59 |
Operating Profit | 109.14 | 137.16 | 128.91 |
Other Income | 17.68 | 37.00 | 35.81 |
Interest | 4.19 | 6.62 | 3.15 |
Depreciation | 13.76 | 8.83 | 5.75 |
Profit Before Tax | 91.19 | 121.71 | 120.01 |
Tax | 23.69 | 29.38 | 45.58 |
Profit After Tax | 67.50 | 92.33 | 74.43 |
Share Capital | 10.31 | 10.31 | 10.31 |
Reserves | 745.33 | 672.63 | 592.96 |
Net Worth | 755.64 | 682.94 | 603.27 |
Loans | 94.34 | 95.52 | 73.44 |
Gross Block | 211.63 | 203.03 | 94.14 |
Investments | 18.30 | 18.31 | 18.31 |
Cash | 119.52 | 86.62 | 93.29 |
Debtors | 348.68 | 404.91 | 342.09 |
Net Working Capital | 654.51 | 580.60 | 536.48 |
Operating Profit Margin (%) | 23.45 | 31.04 | 30.22 |
Net Profit Margin (%) | 14.50 | 20.89 | 17.45 |
Earning Per Share (Rs) | 6.54 | 8.95 | 7.22 |
Dividend (%) | 50.00 | 50.00 | 100.00 |
Dividend Payout | 5.16 | 12.41 | 12.41 |
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices